Up-regulated miR-196a promotes gastric cancer MGC-803 cells migration and invasion by regulating HOXA5 expressionYIN Lingdi, SUN Qian, LIN Mengjie, SUN Ming, DE Wei, LIU Zhijun193-198
Expression of MTSS1 and its clinicopathological significance in non-small cell lung cancerFANG Wenzheng, HONG Junfeng, WU Dansen, LIN Shaoqin, YU Zongyang, CHEN Xi, OUYANG Xuenong199-203
Expression of CK19 and MUC-1 mRNA in the peripheral blood of patients with colorectal cancer and their clinical significancesWANG Qian, LIU Jie, AN Zewu204-207
Expression of miR-455-3p and its relationship with MVD and VEGF in gastric carcinomaSONG Jianqing, CAO wei, LYU Haoyue208-211
Expression and clinical significance of FLNA in renal cell carcinomaSUN Guogui, CUI Dawei, CHENG Yunjie, JING Shaowu, HU Wanning212-215
Expression and clinical significance of EphA2 in diffuse large B-cell lymphomaHUANG Xiaoyin, WANG Jiandong, SUN Qian, FU Haijin, GUAN Xiaoxiang, WANG Jinghua216-220
Expressions and clinical significance of B7-H1 in malignant cutaneous tumorsZHENG Yunyan, CHEN Lujun, XU Bin, JIANG Jingting, WU Changping221-225
Clinical observation of oxaliplatin-based regimen for sorafenib-resistant advanced primary liver carcinomaWANG Feng, QIN Shukui, HUA Haiqing, LIU Xiufeng, YANG Liuqing, QU Wenshu226-230
Clinical observation of modified DCF regimen versus FOLFOX 4 regimen as first-line treatment for ad-vanced gastric cancerZHANG Fang, CHEN Yamin, JING Chao, LI Jingzhe, SHI Peng231-234
The dosimetric comparison and clinical observation between box technique and IMRT in whole pelvic ra-diotherapy of stage ⅡB cervical carcinomaRUAN Shasha, WU Gang, DING Qian, SONG Yingqiu, LI Guiling235-239
